ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 1064

Unique Profile of Cardiovascular Risk Factors in Rheumatoid Arthritis High-Risk Populations with Insufficient Risk Control

Ulf Müller-Ladner1, Stefan Kleinert2, Klaus Krüger3, Bianca Wittig4 and Rolf Hecker4, 1Rheumatologie und klinische Immunologie, Kerckhoff-Klinik GmbH, Abt. Rheumatologie und klinische Immunologie, Bad Nauheim, Germany, 2Rheumatologie, Praxisgemeinschaft Rheumatologie-Nephrologie, Rheumatologische Schwerpunktpraxis, Erlangen, Germany, 3Praxiszentrum St. Bonifatius, München, Germany, 4Abbvie Deutschland GmbH & Co. KG, Wiesbaden, Germany

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Cardiovascular disease, Diabetes, Elderly, rheumatoid arthritis (RA) and risk assessment

  • Tweet
  • Email
  • Print
Session Information

Session Title: Epidemiology and Public Health (ACR): Rheumatoid Arthritis and Systemic Lupus Erythematosus Outcomes

Session Type: Abstract Submissions (ACR)

Background/Purpose

More than 50% of premature deaths in patients with rheumatoid arthritis (RA) are due to cardiovascular disease (CVD). Both the cumulative burden of inflammation and the increased prevalence of conventional CVD risk factors contribute to this increase in CVD. CVD risk screening and management is therefore mandatory.1

Methods

A cross-sectional study was conducted to screen RA patients for CVD risk factors at rheumatology outpatient centers in Germany. Age, gender, smoking habits, blood pressure, and lipid levels were assessed, as well as medications, comorbidities, DAS28, CVD, and standard laboratory parameters. Using these parameters, a subset of patients was assigned to 3 high-risk CVD subgroups: patients with manifest CVD, patients with diabetes mellitus (DM; type 1 or 2), and, as the CVD mortality risk is a function of age, patients ≥70 years of age. Achievement of target values for CVD risk factors adopted from the European Society of Cardiology (ESC) and European League Against Rheumatism (EULAR) recommendations were compared within these groups.1,2 Descriptive data analysis was performed without adjusting for confounders. The RA population without those risks was used as a comparator group and stratified into risk categories by the mSCORE model.2

Results

The comparator population included 866 patients with RA. High-risk subgroups included 146 RA patients with existing CVD, 111 RA patients with DM (28 aged ≥70 years) and 114 RA patients aged ≥70 years but without DM or CVD. 49% of the CVD patients had a previous myocardial infarction or stroke, 62% had coronary heart disease (CHD), and 22% had previous arterial occlusion events. Recommended target values for CVD risk factors were not achieved by a substantial number of patients even in the high risk populations. Depending on the subgroup, 40%–45% of the patients achieved low disease activity or DAS remission, 41%–63% reached the respective blood pressure target, and 0%–28% reached the low-density lipoprotein (LDL) cholesterol target (Table 1). Lipid target values were rarely achieved in high-risk populations. Only a minor fraction of patients received statin therapy; there was no difference in glucocorticoid use between the high-risk and comparator populations. 65% of the investigators stated that the EULAR recommendations for the management of CVD risk in RA influenced their diagnostic and therapeutic concept.

Conclusion

Target values for CVD risk factors are rarely achieved in high-risk RA patients in routine outpatient settings, reflecting the insufficient management of CVD risk.

References

1. Peters MJL, et al. Ann Rheum Dis. 2010;69:325-331. 2. Perk J, et al. Eur Heart J. 2012;33:1635-1701.


Disclosure:

U. Müller-Ladner,

AbbVie Deutschland GmbH & Co. KG,

5,

AbbVie Deutschland GmbH & Co. KG,

8;

S. Kleinert,

AbbVie Deutschland GmbH & Co. KG,

5,

AbbVie Deutschland GmbH & Co. KG,

8;

K. Krüger,

AbbVie Deutschland GmbH & Co. KG,

5,

AbbVie Deutschland GmbH & Co. KG,

8;

B. Wittig,

AbbVie Deutschland GmbH & Co. KG,

3;

R. Hecker,

AbbVie Deutschland GmbH & Co. KG,

3,

AbbVie Deutschland GmbH & Co. KG,

1.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/unique-profile-of-cardiovascular-risk-factors-in-rheumatoid-arthritis-high-risk-populations-with-insufficient-risk-control/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2022 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies